New patent expiration for Novartis Pharm drug AFINITOR DISPERZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for AFINITOR+DISPERZ
Annual Drug Patent Expirations for AFINITOR+DISPERZ

Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for AFINITOR DISPERZ.

The generic ingredient in AFINITOR DISPERZ is everolimus. One supplier is listed for this compound. Additional details are available on the everolimus profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top